dijous, 16 de març del 2017

Medtech stocks slump on 18% NIH cut in Trump budget plan

Trump budget proposalThe Trump budget plan to slash 20% from the budget for the National Institutes of Health sent medical device stocks down today on Wall Street as investors reacted to the proposal.

The budget proposal, released today, would cut the NIH budget by $5.8 billion, to $25.9 billion – an 18.3% cut. The proposal would also introduce “a major reorganization of NIH’s Institutes and Centers to help focus resources on the highest priority research and training activities.”

The proposal would eliminate the Fogarty International Center, a global health-focused organization, and consolidate the Agency for Healthcare Research & Quality. It also includes “other consolidations and structural changes across NIH organizations and activities” and “reduces administrative costs and rebalance[s] Federal contributions to research funding.”

Investors reacted by sending medical device and other healthcare related stocks down today:

COMPANY SHARE PRICE % CHANGE
Boston Scientific (NYSE:BSX) $24.38 -1.1%
C.R. Bard (NYSE:BCR) $248.69 -0.8%
Teleflex (NYSE:TFX) $194.75 -1.2%
Becton Dickinson & Co. (NYSE:BDX) $181.00 -1.9%
Edwards Lifesciences (NYSE:EW) $93.30 -0.7%
Abbott (NYSE:ABT) $44.83 -1.0%
LivaNova (NSDQ:LIVN) $49.71 -0.5%
Medtronic (NYSE:MDT) $82.21 -1.3%
Integra LifeSciences (NSDQ:IART) $42.38 -2.0%
Zimmer Biomet (NYSE:ZBH $119.34 -0.3%
Stryker (NYSE:SYK) $131.09 -1.3%
NuVasive Inc. (NSDQ:NUVA) $74.13 -1.0%
Johnson & Johnson (NYSE:JNJ) $128.25 -0.6%
Globus Medical (NYSE:GMED) $27.88 -0.3%
Orthofix (NSDQ:OFIX) $39.11 -1.3%

The post Medtech stocks slump on 18% NIH cut in Trump budget plan appeared first on MassDevice.



from MassDevice http://ift.tt/2mTeTqz

Cap comentari:

Publica un comentari a l'entrada